Scarlett K. Schneider, Ph.D., has been selected as the senior director of development to lead fundraising efforts at the West Virginia University Cancer Institute.
A native of Clarksburg, W.Va., Schneider comes to WVU from The University of Pennsylvania where she served as executive director of athletics development and oversaw an extensive list of multi-million dollar fundraising initiatives.
“I am thrilled to be returning to West Virginia,” said Schneider. “I am truly honored to accept this important role to serve and lead the development efforts at the WVU Cancer Institute. The Cancer Institute is experiencing great momentum under the leadership and vision of Dr. Richard Goldberg. I am grateful to the selection committee and the University leadership. I look forward to working closely with them to provide the valuable funding resources needed to accelerate discoveries and to transform our ability to treat the citizens of West Virginia and surrounding communities.”
“We are delighted to welcome Scarlett back to West Virginia and to take advantage of her professional experience and skills as leader of our development team at this time of unprecedented growth in the Cancer Institute,” said Richard Goldberg, MD, director of the WVU Cancer Institute. “We have some great opportunities to work on together.”
Prior to arriving at The University of Pennsylvania, Schneider served as the senior executive director of development and associate athletic director for The George Washington University in Washington, D.C.; the director of athletic development for the University of Delaware; and held similar positions at The Ohio State University as well as Virginia Polytechnic Institute and State University.
Schneider is currently the president of the National Association of Athletic Development Directors and has been involved with the organization since 1996.
“We are honored to be welcoming Scarlett to the team,” said George Omiros, associate vice president for Health Sciences Development with the WVU Foundation. “The Cancer Institute is at a pivotal moment in treating one of the most extensive burdens on this state. Incredible accomplishments have been made in treatment, prevention and research, and Scarlett’s fundraising expertise and ideas will allow for the Cancer Institute to continue to serve the people of West Virginia and beyond.”
Schneider holds three degrees from Virginia Tech: a bachelor’s degree in marketing education, master’s degree in sports management administration and a Ph.D. of education in education administration and higher education.
CONTACT: Hannah d'Entremont
WVU Health Sciences Office of Philanthropy
304-293-1735 | firstname.lastname@example.org
WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors
The WVU Cancer Institute is participating in the implementation of a new drug therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a type of tumor that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix. These life-threatening tumors can spread to other organs, such as the liver.
Meshea Poore, vice president for the Division of Diversity, Equity and Inclusion at WVU, will be the special guest at a Health Sciences Town Hall during WVU’s Diversity Week celebrations.
With severe storm approaching the East Coast, WVU reminds campus community about safety and resources
The West Virginia University Police and Office of Emergency Management urges students, faculty and staff to be prepared as the state braces for the impact of Hurricane Florence, making landfall along the East Coast later this week.